Healthcare provider profile · identity verified

Angelo N Georges, MD

Internal Medicine · WHEELING, WV · NPI 1821094038

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	403	102
Levothyroxine Sodium	Levothyroxine Sodium	337	69
Atorvastatin Calcium	Atorvastatin Calcium	304	84
Rosuvastatin Calcium	Rosuvastatin Calcium	299	85
Omeprazole	Omeprazole	297	80
Furosemide	Furosemide	227	76
Tamsulosin Hcl	Tamsulosin Hcl	205	58
Potassium Chloride	Potassium Chloride	191	58
Allopurinol	Allopurinol	189	44
Metformin Hcl	Metformin Hcl	181	57
Olmesartan Medoxomil	Olmesartan Medoxomil	181	47
Losartan Potassium	Losartan Potassium	170	44
Simvastatin	Simvastatin	166	45
Amlodipine Besylate	Amlodipine Besylate	150	43
Eliquis	Apixaban	141	28
Celecoxib	Celecoxib	138	45
Alprazolam	Alprazolam	125	20
Famotidine	Famotidine	122	25
Prednisone	Prednisone	114	75
Lorazepam	Lorazepam	110	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	109	12
Glimepiride	Glimepiride	107	26
Pantoprazole Sodium	Pantoprazole Sodium	107	34
Atenolol	Atenolol	106	29
Lisinopril	Lisinopril	102	23
Meloxicam	Meloxicam	101	39
Hydrochlorothiazide	Hydrochlorothiazide	100	29
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	93	28
Tramadol Hcl	Tramadol Hcl	89	20
Escitalopram Oxalate	Escitalopram Oxalate	87	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	23
Metoprolol Tartrate	Metoprolol Tartrate	86	19
Pravastatin Sodium	Pravastatin Sodium	85	23
Synthroid	Levothyroxine Sodium	82	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	78	58
Ibuprofen	Ibuprofen	77	22
Januvia	Sitagliptin Phosphate	74	15
Ozempic	Semaglutide	74	11
Dutasteride	Dutasteride	72	15
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	71	23
Fenofibrate	Fenofibrate Nanocrystallized	70	19
Clopidogrel	Clopidogrel Bisulfate	68	18
Jardiance	Empagliflozin	68	21
Trazodone Hcl	Trazodone Hcl	68	14
Duloxetine Hcl	Duloxetine Hcl	65	18
Temazepam	Temazepam	61	11
Zolpidem Tartrate	Zolpidem Tartrate	59	14
Fluticasone Propionate	Fluticasone Propionate	57	16
Finasteride	Finasteride	56	15
Gabapentin	Gabapentin	55	17
Ropinirole Hcl	Ropinirole Hcl	55	suppressed
Ezetimibe	Ezetimibe	53	14
Ondansetron Odt	Ondansetron	53	25
Albuterol Sulfate Hfa	Albuterol Sulfate	49	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	46	15
Azithromycin	Azithromycin	43	38
Solifenacin Succinate	Solifenacin Succinate	43	12
Esomeprazole Magnesium	Esomeprazole Magnesium	40	14
Farxiga	Dapagliflozin Propanediol	40	suppressed
Fenofibrate	Fenofibrate	40	suppressed
Valsartan	Valsartan	40	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	39	suppressed
Cefdinir	Cefdinir	38	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	29
Meclizine Hcl	Meclizine Hcl	37	21
Nebivolol Hcl	Nebivolol Hcl	35	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Sertraline Hcl	Sertraline Hcl	34	13
Digoxin	Digoxin	33	suppressed
Lovastatin	Lovastatin	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Spironolactone	Spironolactone	29	11
Telmisartan	Telmisartan	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Fentanyl	Fentanyl	26	suppressed
Indapamide	Indapamide	26	suppressed
Santyl	Collagenase Clostridium Hist.	26	suppressed
Galantamine Hbr	Galantamine Hbr	25	suppressed
Bumetanide	Bumetanide	24	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	24	18
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Ramipril	Ramipril	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	15
Donepezil Hcl	Donepezil Hcl	21	suppressed
Fluconazole	Fluconazole	21	13
Levofloxacin	Levofloxacin	21	15
Lansoprazole	Lansoprazole	20	suppressed
Tresiba Flextouch U-100	Insulin Degludec	20	suppressed
Baclofen	Baclofen	19	suppressed
Clonazepam	Clonazepam	19	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Risedronate Sodium	Risedronate Sodium	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Nitroglycerin Patch	Nitroglycerin	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Dofetilide	Dofetilide	16	suppressed
Etodolac	Etodolac	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	15
Terazosin Hcl	Terazosin Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Tresiba Flextouch U-200	Insulin Degludec	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Montelukast Sodium	Montelukast Sodium	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error